Patents by Inventor Dennis Saadeh

Dennis Saadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYDRIATIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
    Publication number: 20240058320
    Abstract: Pharmaceutical compositions for intraocular injection and for topical administration are described, the compositions comprise therapeutically effective quantity of at least two mydriatic compounds, a non-steroid anti-inflammatory drug, and further, optionally, a gel forming compound, an anesthetic, an antibiotic, and a metal chelator. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: December 9, 2021
    Publication date: February 22, 2024
    Inventor: DENNIS SAADEH
  • OPHTHALMIC DYE COMPOSITION AND METHOD FOR ADMINISTERING SAME
    Publication number: 20230277694
    Abstract: The present disclosure encompasses methods and compositions for staining ocular structures in ophthalmologic procedures. The compositions generally include a mydriatic compound and a dye. The compositions may additionally include a pain-relieving compound and a second mydriatic compound. Also provided herein is a method of delivering a pharmaceutical composition, which includes administering to an eye of a subject an ophthalmic pharmaceutical composition of the present disclosure.
    Type: Application
    Filed: March 3, 2023
    Publication date: September 7, 2023
    Inventors: Dennis Saadeh, William Wiley, Mark Baum
  • METHOD AND COMPOSITION FOR TREATING INFECTIOUS CONJUNCTIVITIS
    Publication number: 20230181625
    Abstract: The present invention relates generally to a method of treating infectious conjunctivitis by administering to an infected eye of a subject a composition comprising povidone-iodine and an excipient that reduces the ocular toxicity of the composition, wherein the composition does not include a steroidal anti-inflammatory drug or a non-steroidal anti-inflammatory drug.
    Type: Application
    Filed: December 14, 2021
    Publication date: June 15, 2023
    Inventor: Dennis Saadeh
  • PACKAGED COMPOSITIONS COMPRISING HYPOCHLOROUS ACID AND MENTHOL AND METHODS OF MAKING THEREOF
    Publication number: 20230181630
    Abstract: The present disclosure relates to packaged eyelid scrubs as well as methods for making the packaged eyelid scrubs. The packaged eyelid scrubs include a pharmaceutical composition that includes hypochlorous acid and menthol, and a package that includes an opaque airless spray container filled with the pharmaceutical composition. Methods of cleansing an eyelid using the pharmaceutical compositions are also described herein.
    Type: Application
    Filed: December 9, 2022
    Publication date: June 15, 2023
    Inventors: Dennis Saadeh, Mark Baum
  • EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
    Publication number: 20210346318
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 11, 2021
    Inventors: John Scott Karolchyk, Mark L. Baum, Dennis Saadeh
  • Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
    Patent number: 10383875
    Abstract: The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: August 20, 2019
    Assignee: HARROW IP, LLC
    Inventors: Matthew J. Buderer, Dennis Saadeh, Andrew R. Boll
  • PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES, AND THEIR USE
    Publication number: 20170319590
    Abstract: The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.
    Type: Application
    Filed: June 12, 2017
    Publication date: November 9, 2017
    Inventors: Matthew J. Buderer, Dennis Saadeh, Andrew R. Boll